Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 65% ± 11% | |
Mueller cell | 4 studies | 42% ± 21% |
Insufficient scRNA-seq data for expression of TRH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 88% | 420.32 | 2335 / 2642 | 69% | 17.37 | 489 / 705 |
ovary | 94% | 302.08 | 169 / 180 | 13% | 0.49 | 56 / 430 |
breast | 36% | 171.71 | 164 / 459 | 39% | 54.99 | 440 / 1118 |
uterus | 49% | 215.24 | 84 / 170 | 10% | 1.14 | 46 / 459 |
lung | 56% | 23.00 | 325 / 578 | 3% | 0.29 | 32 / 1155 |
adrenal gland | 10% | 2.80 | 26 / 258 | 20% | 5.93 | 47 / 230 |
spleen | 26% | 7.95 | 62 / 241 | 0% | 0 | 0 / 0 |
prostate | 22% | 11.01 | 53 / 245 | 1% | 0.04 | 4 / 502 |
heart | 22% | 19.12 | 190 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 7.61 | 187 / 929 | 0% | 0 | 0 / 0 |
kidney | 18% | 6.53 | 16 / 89 | 1% | 0.02 | 9 / 901 |
adipose | 18% | 6.31 | 214 / 1204 | 0% | 0 | 0 / 0 |
skin | 16% | 4.70 | 291 / 1809 | 1% | 0.02 | 7 / 472 |
eye | 0% | 0 | 0 / 0 | 14% | 4.47 | 11 / 80 |
blood vessel | 10% | 2.03 | 133 / 1335 | 0% | 0 | 0 / 0 |
thymus | 8% | 1.44 | 50 / 653 | 0% | 0.07 | 3 / 605 |
bladder | 5% | 3.67 | 1 / 21 | 1% | 5.82 | 4 / 504 |
liver | 3% | 0.84 | 7 / 226 | 2% | 0.11 | 7 / 406 |
esophagus | 2% | 0.46 | 32 / 1445 | 2% | 0.03 | 4 / 183 |
stomach | 2% | 0.28 | 6 / 359 | 2% | 0.03 | 5 / 286 |
intestine | 1% | 0.41 | 14 / 966 | 1% | 0.04 | 5 / 527 |
muscle | 1% | 0.25 | 10 / 803 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.04 | 1 / 328 | 0% | 0 | 0 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007628 | Biological process | adult walking behavior |
GO_0014054 | Biological process | positive regulation of gamma-aminobutyric acid secretion |
GO_0001692 | Biological process | histamine metabolic process |
GO_0014050 | Biological process | negative regulation of glutamate secretion |
GO_0042755 | Biological process | eating behavior |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0007267 | Biological process | cell-cell signaling |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0030141 | Cellular component | secretory granule |
GO_0005576 | Cellular component | extracellular region |
GO_0005515 | Molecular function | protein binding |
GO_0008437 | Molecular function | thyrotropin-releasing hormone activity |
Gene name | TRH |
Protein name | Pro-thyrotropin-releasing hormone Pro-thyrotropin-releasing hormone (Pro-TRH) (Prothyroliberin) [Cleaved into: Thyrotropin-releasing hormone (TRH) (Protirelin) (TSH-releasing factor) (Thyroliberin) (Thyrotropin-releasing factor) (TRF)] |
Synonyms | |
Description | FUNCTION: As a component of the hypothalamic-pituitary-thyroid axis, it controls the secretion of thyroid-stimulating hormone (TSH) and is involved in thyroid hormone synthesis regulation. It also operates as modulator of hair growth. It promotes hair-shaft elongation, prolongs the hair cycle growth phase (anagen) and antagonizes its termination (catagen) by TGFB2. It stimulates proliferation and inhibits apoptosis of hair matrix keratinocytes. . FUNCTION: Functions as a regulator of the biosynthesis of TSH in the anterior pituitary gland and as a neurotransmitter/ neuromodulator in the central and peripheral nervous systems. . |
Accessions | P20396 ENST00000507066.1 ENST00000302649.4 D6RFM1 |